These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6900937)
1. Dantrium: the approved drug to control malignant hyperthermia. Gever LN Nursing; 1980 Jul; 10(7):62. PubMed ID: 6900937 [No Abstract] [Full Text] [Related]
2. Dantrolene sodium in the treatment of malignant hyperthermia. A case report. Harrison GG S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773 [TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia and the conscious patient. Kemp DR; Choong LS Aust N Z J Surg; 1988 May; 58(5):423-7. PubMed ID: 3178598 [TBL] [Abstract][Full Text] [Related]
4. Dantrolene for malignant hyperthermia during anesthesia. Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124 [No Abstract] [Full Text] [Related]
5. Dantrolene sodium and management of malignant hyperthermia. Fuerst DL; Toth AJ AANA J; 1983 Aug; 51(4):406-10. PubMed ID: 6556878 [No Abstract] [Full Text] [Related]
6. Dantrolene sodium approved for malignant hyperthermia. FDA Drug Bull; 1979 Nov; 9(5):27. PubMed ID: 510837 [No Abstract] [Full Text] [Related]
7. Malignant hyperthermia in the ambulatory surgery center: how should we prepare? Litman RS; Joshi GP Anesthesiology; 2014 Jun; 120(6):1306-8. PubMed ID: 24710219 [No Abstract] [Full Text] [Related]
8. Malignant hyperthermia. Considerations for the ophthalmologist. Sedwick LA; Romano PE Surv Ophthalmol; 1981; 25(6):378-82. PubMed ID: 7245023 [TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia with excellent response to small dose of dantrolene. Chang KY; Ting CK; Chan KH; Tsai SK Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136 [TBL] [Abstract][Full Text] [Related]
10. [Malignant hyperthermia. Current aspects of dantrolene treatment of 2 cases of hyperthermia maligna incipiens]. Hoffmann-Lundgren B; Kühn K; Hausdörfer J Anasth Intensivther Notfallmed; 1982 Jun; 17(3):169-70. PubMed ID: 7125160 [TBL] [Abstract][Full Text] [Related]
12. Readiness for malignant hyperthermia can be survey stumbling block. Traynor K Am J Health Syst Pharm; 2016 Jun; 73(12):852-3. PubMed ID: 27261225 [No Abstract] [Full Text] [Related]
13. Recognizing and treating malignant hyperthermia. Corvetto MA; Taekman JM Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479 [No Abstract] [Full Text] [Related]
14. Malignant hyperthermia: a review of the literature. Rodgers IR Mt Sinai J Med; 1983; 50(1):95-8. PubMed ID: 6341821 [No Abstract] [Full Text] [Related]
16. Malignant hyperthermia: clinical course and metabolic changes in two patients. Rutberg H; Håkanson E Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577 [TBL] [Abstract][Full Text] [Related]
17. Advances in the diagnosis and treatment of malignant hyperthermia. Aldrete JA Acta Anaesthesiol Scand; 1981 Dec; 25(6):477-83. PubMed ID: 7347075 [No Abstract] [Full Text] [Related]
18. Malignant Hyperthermia: From the OR to the Sidelines. Nelson TE Curr Sports Med Rep; 2018 Aug; 17(8):254-255. PubMed ID: 30095544 [No Abstract] [Full Text] [Related]
19. Malignant hyperthermia. Ben Abraham R; Adnet P; Glauber V; Perel A Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480 [TBL] [Abstract][Full Text] [Related]
20. Malignant hyperthermia: not just an operating room emergency. Young MS; Kindred D Medsurg Nurs; 1993 Feb; 2(1):41-3, 46. PubMed ID: 7686428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]